Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations
- 1 August 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (8) , 1368-1372
- https://doi.org/10.1128/aac.33.8.1368
Abstract
The susceptibilities of 270 clinical isolates of Pseudomonas aeruginosa from diverse sources (82 burn patients, 76 cystic fibrosis [CF] patients, and 112 other sources) to ciprofloxacin and three other quinolones, nine extended-spectrum beta-lactams, and three aminoglycosides were determined by an agar dilution method in cation-supplemented Mueller-Hinton medium. Ciprofloxacin, ceftazidime, imipenem, and aztreonam were the most active. MICs for burn isolates were consistently higher than those for other isolates for most antibiotics, whereas those for CF strains were consistently lower. Multidrug resistance to aminoglycosides and beta-lactams occurred in 21% of the burn isolates, 2.6% of the CF isolates, and 8.9% of the other isolates. Ninety percent of these strains remained susceptible to ciprofloxacin. Seven percent of the isolates were resistant to ciprofloxacin (MIC, greater than or equal to 2 micrograms/ml). Concurrent resistance to ciprofloxacin and beta-lactams or aminoglycosides was rare (1.8 to 4%). Analysis by Spearman rank correlation revealed a high degree of correlation of MICs among antibiotics within the same class, except for imipenem. An inoculum effect was observed for all antibiotics between 10(6) and 10(4) CFU (P less than 0.05), with those for piperacillin and cefoperazone being the most pronounced (16-fold and 8-fold differences, respectively), and was least apparent for the quinolones, aminoglycosides, imipenem, and aztreonam (twofold differences). Selected strains for which there were high MICs of ciprofloxacin (greater than or equal to 1 micrograms/ml) were tested against ciprofloxacin in combination with other agents in a checkerboard agar dilution assay. Synergistic (summated fractional inhibitory concentration, /= 4) was observed in only one instance (with gentamicin).This publication has 30 references indexed in Scilit:
- ANALYSIS OF THE INTERACTION BETWEEN PIPERACILLIN AND CIPROFLOXACIN OR TOBRAMYCIN AGAINST THIRTEEN STRAINS OF PSEUDOMONAS AERUGINOSA, USING KILLING CURVESActa Pathologica Microbiologica Scandinavica Series B: Microbiology, 1987
- Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of pseudomonasDiagnostic Microbiology and Infectious Disease, 1987
- Synergy of Imipenem – A Novel Carbapenem, and Rifampin and Ciprofloxacin against Pseudomonasaeruginosa, Serratiamarcescens and Enterobacter SpeciesChemotherapy, 1987
- Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620Antimicrobial Agents and Chemotherapy, 1986
- Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strainsAntimicrobial Agents and Chemotherapy, 1985
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620Antimicrobial Agents and Chemotherapy, 1985
- In-vitro activity of ciprofioxacin and other antibacterial agents against Pseudonwnas aeruginosa and Pseudomonas cepacia from cystic fibrosis patientsJournal of Antimicrobial Chemotherapy, 1985
- In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1985
- Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Cephradine concentrations in serum, pleural fluid, pleura, and lung of normal rabbitsJournal of Antimicrobial Chemotherapy, 1981